January 23, 2018

New Expert Recommendations on Assessing Atrial Fibrillation Stroke and Bleeding Risk for Appropriate Anticoagulation

The Atrial Fibrillation Optimal Treatment Task Force, led by the Alliance for Aging Research, has just released a consensus statement developed by a group of leading afib stroke prevention experts. We at StopAfib.org are proud to have been part of the development of this consensus statement, which recommends a process for assessing afib stroke and […]

Rivaroxaban (Xarelto) Effective for Atrial Fibrillation Patients with High Stroke Risk

Just ahead of the FDA Advisory Committee hearing on rivaroxaban for stroke prevention in atrial fibrillation, we report in more depth on the ROCKET-AF trial results published recently in the New England Journal of Medicine. Rivaroxaban was shown to be as effective as warfarin (Coumadin) for stroke prevention in a high-risk afib population. To learn […]

StopAfib.org Stroke Awareness Month Activities Focus on Averting an Atrial Fibrillation Stroke Crisis

For Stroke Awareness Month in May, StopAfib.org, an atrial fibrillation patient advocacy organization for those living with atrial fibrillation, recounted the activities focused on raising awareness of atrial fibrillation to avert a stroke crisis. These included continued participation in the Facing AFib campaign, which launched a new pledge by spokesperson Susan Lucci and her husband […]